NCT04657068 2026-03-18A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsArtios Pharma LtdPhase 1/2 Recruiting442 enrolled
NCT06993844 2026-03-17Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsEnsem TherapeuticsPhase 1/2 Recruiting233 enrolled
NCT06433219 2026-02-18Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)EMD SeronoPhase 2 Active not recruiting63 enrolled
NCT06463028 2025-12-24Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerFaeth TherapeuticsPhase 2 Recruiting40 enrolled
NCT05683418 2025-07-22A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid TumorsTotus MedicinesPhase 1 Recruiting241 enrolled
NCT01226316 2025-06-29Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment SchedulesAstraZenecaPhase 1 Completed285 enrolled
NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled